Full-Time

Clinical Development Engineer 2

Posted on 8/14/2025

Neptune Medical

Neptune Medical

1-10 employees

At-home fertility diagnostics and non-invasive device

Compensation Overview

$110k - $160k/yr

+ Equity + 401(k) Match

Burlingame, CA, USA

In Person

Category
Biology & Biotech (2)
,
Requirements
  • B.S. in Biomedical Engineering or similar
  • 2+ years of work experience within the medical device industry
  • Experience collaborating with physicians and collecting feedback on clinical use of the product
  • Experience leading hands-on product evaluation testing in a pre-clinical lab
  • Fluent in medical terminology and sound knowledge of anatomy
  • Excellent verbal and written communications skills required including presentation of technical content
  • Ability to draw conclusions and make recommendations based on technical inputs from multiple and varied sources
  • Takes initiative and acts quickly to drive to solutions with a driven outlook and with a strong desire to succeed as an engineer, as a team player, and as a key part of a company
  • An inventive aptitude balanced with discipline and detail-orientation
  • A self-starter needing minimal supervision and able to adapt priorities in a fast paced, dynamic product development team.
Responsibilities
  • Collaborate with Product Development and Clinicians to define user needs for product
  • Drive product discovery in collaboration with product management and product development teams by being the internal champion of clinical need
  • Become the subject matter expert on GI anatomy, disease states, and clinical procedures and environments
  • Utilize clinical knowledge to lead the development of bench models for evaluation of prototypes
  • Remain current with the latest GI scientific publications relevant to the company’s products
  • Assess potential clinical risks and propose mitigations as an input to product design
  • Develop new test methods, models, and metrics for quantifying product performance
  • Own and manage pre-clinical testing facilities
  • Write plans, protocols, conduct formal testing, and report results of preclinical, formative, summative, and validation studies throughout the design process
  • Support developing customer training materials, user manuals, labeling, and other supporting materials
  • Support initial product launch by developing customer training activities, supporting initial cases during customer site bring up, and conducting Physician Preference Testing
Desired Qualifications
  • M.S. in Biomedical Engineering or similar
  • Experience developing design validation strategy, protocol creation and testing
  • Experience in clinical development for medical robotics
  • Experience in the regulated medical device environment, including but not limited to document control processes, design control processes, protocol development, and report writing
  • Experience developing bench models of disease states
  • Experience or knowledge of the GI/endoscopy space
  • Experience in conducting risk assessments
  • Experience and application of usability and human factors principles

Neptune Medical develops devices and tests to address male infertility. Its two main products are Pro-Test, an at-home diagnostic kit that lets individuals test fertility parameters from home, and Neptune, a non-invasive device designed to improve sperm quality. Pro-Test provides a convenient way to assess fertility without clinic visits, while Neptune uses a proprietary, non-invasive method to enhance key sperm metrics and is intended for home use alongside clinical fertility treatment. The company serves both clinics (B2B) and individual consumers (B2C) and markets its products to help diagnose and treat male infertility, a factor in about half of all infertility cases. Neptune Medical differentiates itself by offering integrated, consumer-accessible diagnostics and treatment tools, backed by grant funding and participation in precision medicine programs, aiming to make diagnosis and treatment more private, accessible, and effective.

Company Size

1-10

Company Stage

Series D

Total Funding

$97M

Headquarters

Burlingame, California

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • Varicocele embolization boosts sperm parameters, complementing Neptune's enhancement device.
  • E-cigarette harm awareness drives Pro-Test demand for lifestyle-impacted diagnostics.
  • Innovate UK and Horizon 2020 grants validate clinical innovation for market entry.

What critics are saying

  • Varicocele embolization by University Radiology eliminates Neptune device need in 12-24 months.
  • RSC New Jersey clinics integrate evaluations, cutting Pro-Test demand in 6-18 months.
  • Clomiphene citrate adoption by urologists cannibalizes device market in 12-24 months.

What makes Neptune Medical unique

  • Pro-Test delivers at-home male fertility diagnostics for convenient sperm analysis.
  • Neptune device non-invasively enhances sperm quality via patented home-use technology.
  • Targets male infertility gap, serving B2B clinics and B2C consumers since 2018.

Help us improve and share your feedback! Did you find this helpful?

Benefits

401(k) Company Match

Company Equity

Company News

The Robot Report
Oct 4th, 2024
Robotics Investments Near $1B In August

Listen to this articleSwiss-Mile raised $22M in August 2024 for its wheeled quadruped. Fifty producers of robots and robotics enabling technologies received funding in August 2024, pulling in a total of approximately $1 billion. This figure is on par with the $1.2 billion average The Robot Report has tracked each of the previous 12 months. Investment targeted to robotics companies for the first eight months of 2024 equals about $10.86 billion. You can follow The Robot Report‘s investment section here. The largest investments in August were secured by developers of autonomous driving technologies

Business Wire
Aug 17th, 2024
Neptune Medical Announces $97M Series D Financing and Spinout of Jupiter Endovascular

Neptune Medical announces $97 million in Series D financing, along with the spinout of its Jupiter Endovascular subsidiary.

INACTIVE